TECHNOLOGY SUMMARY
Current and future threats to global biosecurity are predominantly due to infectious pathogens. Our platform technology of molecules bind to DNA at multiple sites to kill pathogens of many different infectious disease types including bacteria, fungi, viruses and parasites, with a unique mechanism of action to delay resistance development.
AREA/MATURITY/AWARDS
Primary Application Area: Biotech, Pharma, Health
Technology Development Status: Prototype
Technology Readiness Level: TRL 4
Vetted Programs/Awards: £20k INSPIRE 100 award out of the University of Strathclyde for the most 'investable' spin out company.
SHOWCASE SUMMARY
Organization Type: Early-stage Startup (Seed)
Website: https://www.rostratx.com
Showcase Booth #: M59
MARKET KEYWORDS
Market Keywords: Infection, fungal, resistance